Literature DB >> 10581976

Psychiatric aspects of parathyroid disease.

P J Velasco1, M Manshadi, K Breen, S Lippmann.   

Abstract

Parathyroid diseases can present with psychiatric symptoms and can be recognized through determinations of serum electrolytes, especially the calcium level. Psychiatric evaluations should include a serum calcium concentration test, which is also essential in reassessment of patients poorly responsive to mental illness treatment. A magnesium and a phosphate assay may also be diagnostically helpful. Abnormality of divalent cation levels may provide evidence for consideration of, or ruling out, parathyroid disorders. Determinations of parathyroid hormone are performed if clinically indicated, and if abnormal divalent cation quantifications are confirmed. If parathyroid disease is identified, corrective endocrine therapies may diminish or even cure psychiatric aspects of parathyroid pathology. Failure to recognize a parathyroid disorder leaves an endocrine-induced mental dysfunction without proper treatment.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10581976     DOI: 10.1016/s0033-3182(99)71186-2

Source DB:  PubMed          Journal:  Psychosomatics        ISSN: 0033-3182            Impact factor:   2.386


  7 in total

1.  Effects of PTH(1-84) therapy on muscle function and quality of life in hypoparathyroidism: results from a randomized controlled trial.

Authors:  T Sikjaer; L Rolighed; A Hess; A Fuglsang-Frederiksen; L Mosekilde; L Rejnmark
Journal:  Osteoporos Int       Date:  2014-04-01       Impact factor: 4.507

Review 2.  Diagnosis and management of hypocalcaemia.

Authors:  Mark S Cooper; Neil J L Gittoes
Journal:  BMJ       Date:  2008-06-07

3.  Secondary psychoses: an update.

Authors:  Matcheri S Keshavan; Yoshio Kaneko
Journal:  World Psychiatry       Date:  2013-02       Impact factor: 49.548

Review 4.  PTH replacement therapy of hypoparathyroidism.

Authors:  L Rejnmark; T Sikjaer; L Underbjerg; L Mosekilde
Journal:  Osteoporos Int       Date:  2012-11-27       Impact factor: 4.507

5.  A case of acute psychosis in an adolescent male.

Authors:  Ghufran Babar; Ramin Alemzadeh
Journal:  Case Rep Endocrinol       Date:  2014-03-30

Review 6.  Hypocalcaemia in patients with prostate cancer treated with a bisphosphonate or denosumab: prevention supports treatment completion.

Authors:  Jean-Jacques Body; Roger von Moos; Daniela Niepel; Bertrand Tombal
Journal:  BMC Urol       Date:  2018-09-20       Impact factor: 2.264

7.  Low health-related quality of life in hypoparathyroidism and need for PTH analog.

Authors:  Georgios Kontogeorgos; Zoi Mamasoula; Emily Krantz; Penelope Trimpou; Kerstin Landin-Wilhelmsen; Christine M Laine
Journal:  Endocr Connect       Date:  2022-01-10       Impact factor: 3.335

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.